Tailored investment concepts
apoAsset offers customized, high-yield, and risk-conscious investment solutions for pension funds, provident institutions, and other capital pools, specializing in multi-asset strategies and healthcare investments.
apoasset.deCrawled Nov 17, 2026
apoAsset offers customized, high-yield, and risk-conscious investment solutions for pension funds, provident institutions, and other capital pools, specializing in multi-asset strategies and healthcare investments.
apoAsset’s multi-asset funds—apo Piano, apo Mezzo, and apo Forte—combine stability and growth, each with distinct risk profiles, to navigate market phases responsibly.
apoAsset’s fund features a clear portfolio structure, professional ETF selection, and tax-efficient reallocations within the fund, balancing global equity and bond investments to manage risk.
apoAsset’s healthcare funds allow investors to participate in growth driven by demographic change, rising prosperity, urbanization, and technological progress in the healthcare sector.
apoAsset’s apo Future Health fund explores future healthcare themes like medtech, diagnostics, AI, and efficiency.
apoAsset’s Global ETFs Portfolio handles ongoing ETF suitability checks, cost/liquidity reviews, and market weighting adjustments.
apoAsset discusses U.S. drug pricing, intermediaries, and regulatory impacts on healthcare investments.
apoAsset provides articles, interviews, and current information in its insights section.
apoAsset highlights healthcare sector opportunities amid rising costs, aging populations, and inefficiencies.
apoAsset’s apo Medical Opportunities fund ranks top in Pharma & Health over 20 years and second over 1 year.
apoAsset and Medical Strategy showcase healthcare market opportunities at the FONDS professionell KONGRESS 2026.
Dr. Lars Edler, an experienced generalist with deep fund expertise, has over two decades of experience in the fund industry, most recently as managing director of Scope Fund Analysis GmbH, where he oversaw analyses of the European fund market.
apoAsset’s multi-asset funds use ESG screenings and active strategies for long-term, diversified portfolios.
apoAsset’s Global ETFs Portfolio earned a "very good" rating in the 2025 Assekurata ranking.
apoAsset, an investment company based in Düsseldorf, manages over 4 billion euros in assets for private and institutional investors, focusing on active asset management in healthcare funds and multi-asset solutions.
apoAsset is an established investment company based in Düsseldorf that manages over 4 billion euros in assets for private and institutional investors, specializing in active asset management since 1999.
apoAsset outlines how innovations like precision oncology and platform technologies improve treatments and investor opportunities.
apoAsset’s structure merges investment expertise with scientific advisory, focusing on multi-asset and healthcare solutions.
apoAsset combines healthcare and multi-asset expertise, offering specialized funds and global networks since 1999.
apoAsset integrates ESG criteria into funds, supporting responsible investing through the Forum Nachhaltige Geldanlagen.
apoAsset provides support for general inquiries, sales topics, and press requests via phone, email, or LinkedIn.
apoAsset and its employees do not participate in public chat groups discussing financial topics or providing investment advice.